{"id":"tp-53875","type":"article-newspaper","title":"MaxCyte Q3 Revenue Rises 49.3% as EPS Loss Beats Estimates","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/53875","datePublished":"2026-11-11T11:24:16.000Z","dateModified":"2026-11-11T11:24:16.000Z","language":"en","abstract":"Revenue reached $10.2 million, including $8.2 million in core revenue and $2 million tied to its SPL program.","section":"Business","references":[{"title":"preliminary Q3 core revenue estimate","url":"https://www.tokenpost.com/news/business/31865"}]}